Organization · Venture Capital
Sirona Capital
Sirona Capital is a healthcare venture capital fund based in Australia, focusing on investments in healthcare innovation and therapeutics, primarily in the US and Canada.
Overview
What Sirona Capital does
What Sirona Capital is
Sirona Capital is a healthcare venture capital fund based in Australia, focusing on investments in healthcare innovation and therapeutics, primarily in the US and Canada.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 23, 2026
Official channels
Find Sirona Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Sirona Capital as a funder
Investment thesis
Sirona Capital invests in healthcare innovation and therapeutics, focusing on life sciences, pharma, biotech, and medical devices. The fund backs visionary entrepreneurs reshaping the healthcare landscape.
Focus narrative
Sirona Capital invests in startups and early-stage companies within the healthcare sector, particularly in medical technology and biopharmaceuticals. The organization seeks to support ideas that have the potential to significantly impact healthcare delivery and patient outcomes.
Value beyond capital
Sirona Capital provides portfolio companies with access to a network of industry experts, key opinion leaders (KOLs), and strategic partners, enhancing their growth potential and market reach.
Focus and fit
- Stages
- Seed · Series A · Series B · Series C · Series D · Series E
- Sectors
- Healthcare · Biotech · Medical Devices
- Regions
- North America · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 14
- Recorded notable exits
- Viela Bio and Constellation Pharmaceuticals
Portfolio context
Notable portfolio companies include: ADARx Pharmaceuticals: Developing next-generation siRNA therapies. Kailera Therapeutics: Focused on next-generation therapies for obesity. OTR Therapeutics: Involved in R&D for therapeutic solutions. CG Oncology: Developing treatments for bladder cancer. Synnovation Therapeutics: Working on innovative cancer therapies. Antiva Biosciences: Specializing in antiviral therapeutics. Constellation Pharmaceuticals: Focused on epigenetics (acquired by MorphoSys/Novartis).
Common questions
What to know about Sirona Capital
Upseed classifies Sirona Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.